I look forward to partnering closely with the clinical development and product strategy teams, and further supporting the Company’s mission to discover and develop life-changing ADCs for patients fighting cancer,” said Dr. “I am delighted to join the Mersana team at such an exciting point in the Company’s lifecycle, as we seek to bring UpRi to ovarian cancer patients in desperate need of new therapeutic options and advance our exciting ADC pipeline. As Mersana’s diversified first-in-class pipeline grows, Brian will continue to ensure Mersana has the resources, partnerships and infrastructure to deliver against our goals.”
Indianfm mohan hits upgrade#
“I would like to thank Brian for his leadership of the Product Strategy function at Mersana and his contributions towards building UpRi into a foundational medicine for ovarian cancer with the UPLIFT, UP-NEXT, and UPGRADE studies.
We are delighted to have Mohan join the Mersana team and welcome his valuable insight as we continue to advance the clinical development of UpRi toward commercialization in ovarian cancer and build out our maturing pipeline of innovative ADC candidates,” commented Anna Protopapas, President and CEO of Mersana. Mohan has overseen the advancement of products through early, mid and late-stage clinical development and has helped launch 7 oncology products globally. “With over 20 years of clinical development and commercialization experience, Mohan is a seasoned biopharmaceutical executive who brings a deep expertise in overall asset strategy and program management to the Mersana team. DeSchuytner will continue to lead finance, business development, corporate strategy and investor relations and remain Mersana’s principal financial officer. Bala will assume strategic product planning responsibilities from Brian DeSchuytner who has been named SVP and Chief Financial Officer. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the appointment of Mohan Bala, Ph.D., as SVP, Strategic Product Planning & Program Leadership, effective Monday, October 25, 2021. 25, 2021 (GLOBE NEWSWIRE) - Mersana Therapeutics, Inc. Those belonging to the BJP and its ideological fountainhead RSS would be well- advised to refrain from making such provocative and irresponsible statements, accept the established realities, and learn to follow the imperatives of peaceful coexistence, it further added.Brian DeSchuytner named SVP and Chief Financial OfficerĬAMBRIDGE, Mass., Oct. “While committed to peace, the people and armed forces of Pakistan are fully capable of defending the sovereignty and territorial integrity of the country.” Pakistan, the Foreign Office said, has consistently opposed India’s hegemonic impulses and demonstrated a firm resolve to thwart any aggressive designs. The reckless misadventures of India, including in February 2019, that seriously imperilled regional peace and stability are also in front of the world.
“The world is witness to the systematic usurpation of the rights of minorities, especially Muslims, in India and the unabated repression of Kashmiris in IIOJK. The FO said this dangerous mindset aims to completely marginalise and dispossess the minorities in India in the internal context while on the external front, it poses an existential threat to all of India’s neighbours in South Asia. “Pakistan has repeatedly highlighted the threat posed to regional peace and stability by the toxic mix of the extremist ‘Hindutva’ ideology (Hindu Rashtra) and expansionist foreign policy (Akhand Bharat) being pursued by the ruling RSS-BJP dispensation in India,” it said.
0 kommentar(er)
